Enable your JavaScript to use Numstock


Numstock » ACRX

ACRX Stock Analysis

The latest metrics for AcelRx Pharmaceuticals, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -2.45
Price / Book Value Ratio < 1.5 -7.47
Price / Sales Ratio < 2.0 54.38
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 -1.84
Price / FCF Ratio Last Year < 15.0 -2.76
Price / FCF Ratio Last Quarter < 15.0 -9.18
Price / TBV Ratio Last Year < 0.7 23.73
Price / TBV Ratio Last Quarter < 0.7 -4.86
Price / NCAV Ratio Last Year < 0.7 -12.18
Price / NCAV Ratio Last Quarter < 0.7 -2.89

Efficiency

Metric Target Value
ROE Last Year > 25.0% 292.3
ROE Last Quarter > 25.0% 54.53
ROA Last Year > 15.0% -39.12
ROA Last Quarter > 15.0% -12.13
ROTA Last Year > 20.0% -34.03
ROTA Last Quarter > 20.0% -12.89
ROIC Last Year > 20.0% 35.13
ROIC Last Quarter > 20.0% 37.78
ROCE Last Year > 20.0% -34.15
ROCE Last Quarter > 20.0% -15.2
Inventory Turnover Last Year > 4.0 20.04
Inventory Turnover Last Quarter > 4.0 1.08
Pre-tax Margin Last Year > 20.0% -2775
Pre-tax Margin Last Quarter > 20.0% -2651
Accounts Payable Turnover Last Year > 3.0 8.27
Accounts Payable Turnover Last Quarter > 3.0 1.21
Accounts Receivable Turnover Last Year > 5.0 42.68
Accounts Receivable Turnover Last Quarter > 5.0 8

Health

Metric Target Value
Current Ratio Last Year > 1.5 6.78
Current Ratio Last Quarter > 1.5 5.38
Quick Ratio Last Year > 1.5 6.73
Quick Ratio Last Quarter > 1.5 5.19
Flow Ratio Last Year < 1.25 2.74
Flow Ratio Last Quarter < 1.25 4.6
Debt / Equity Ratio Last Year < 0.5 0.79
Debt / Equity Ratio Last Quarter < 0.5 -0.78
Debt / EBITDA Ratio Last Year < 4.0 -0.08
Debt / EBITDA Ratio Last Quarter < 4.0 -0.49
Debt / NCAV Ratio Last Year < 2.0 -0.41
Debt / NCAV Ratio Last Quarter < 2.0 -0.46
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.04
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.31
Interest Coverage Ratio Ratio Last Year > 8.0 2.84
Interest Coverage Ratio Last Quarter > 8.0 16.35
FCF / Sales Ratio Last Year > 8.0% -1390
FCF / Sales Ratio Last Quarter > 8.0% -2122

Growth

Metric Target Value
Earnings Yield > 12% -40.86
Ebit Yield Last Year > 12% -21.42
Ebit Yield Last Quarter > 12% -5.42
FCF Yield Last Year > 10% -21.59
FCF Yield Last Quarter > 10% -9.32
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.71
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.2

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -3.55
Altman Z-score Last Quarter ≥ 3.5 -3.95